| Literature DB >> 31117318 |
Setor K Kunutsor1,2, Andrew D Beswick3, Michael R Whitehouse4,5, Ashley W Blom6,7, Erik Lenguerrand8.
Abstract
Prosthetic joint infection (PJI), although uncommon, is a dreaded and devastating complication of total hip replacement (THR). Whether implant-related factors, such as the fixation method, influences the risk of PJI following THR is contentious. We conducted a systematic review and meta-analysis to evaluate the body of evidence linking fixation methods (cemented, uncemented, hybrid, or reverse hybrid) with the risk of PJI following primary THR. Observational studies and randomised controlled trials (RCTs) comparing fixation methods, and reporting PJI incidence following THR, were identified through MEDLINE, Embase, Web of Science, Cochrane Library, and reference lists of relevant studies up to 24 April 2019. Summary measures were relative risks (RRs) (95% confidence intervals, CIs). We identified 22 eligible articles (based on 11 distinct observational cohort studies comprising 2,260,428 THRs and 4 RCTs comprising 945 THRs). In pooled analyses of observational studies, all cemented fixations (plain and antibiotic combined), plain cemented fixations, hybrid fixations, and reverse hybrid fixations were each associated with an increased overall PJI risk when compared with uncemented fixations: 1.10 (95% CI: 1.04-1.17), 1.50 (95% CI: 1.27-1.77), 1.49 (95% CI: 1.36-1.64), and 1.49 (95% CI: 1.14-1.95), respectively. However, in the first six months, uncemented fixations were associated with increased PJI risk when compared to all cemented fixations. Compared to antibiotic-loaded cemented fixations, plain cemented fixations were associated with an increased PJI risk (1.52; 95% CI: 1.36-1.70). One RCT showed an increased PJI risk comparing plain cemented fixations with antibiotic-loaded cemented fixations. Uncemented and antibiotic-loaded cemented fixations remain options for the prevention of PJI in primary THR.Entities:
Keywords: antibiotic-loaded cement; fixation; meta-analysis; primary total hip replacement; prosthetic joint infection; uncemented
Year: 2019 PMID: 31117318 PMCID: PMC6571822 DOI: 10.3390/jcm8050722
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1PRISMA flow diagram.
Characteristics of studies included in review.
| Author, Year of Publication | Year of Study | Country | Indication for THR | Average Age (Years) | Design, Source of Data | Fixation Types Compared | Average Follow-Up Duration, Years | No. of Participants/Hips | Infection Outcome | No. of PJIs | Study Quality |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Wannske, 1979 | NR | Germany | NK | 63.7 | RCT | Cemented with antibiotics, cemented without antibiotics | NK | 476 | Infection | 15 | NA |
| Wykman, 1991 | 1982–1984 | Sweden | Osteoarthritis 77%, rheumatoid arthritis 10%, other 13% | 67.4/64.8 * | RCT | All cemented, uncemented | Over 5.0 | 150 | Infection | 2 | NA |
| Katz, 1992 | 1977–1987 | Canada | Avascular necrosis | 63.0/54.0 * | Observational cohort, Consecutive case series | All cemented, uncemented | 3.8 | 34 | Infection | 1 | 6 |
| Laupacis,2002 | 1987–1992 | Canada | Osteoarthritis | 64.0 | RCT | All cemented, uncemented | 6.3 | 250 | Infection | 2 | NA |
| Engesaeter, 2006 | 1987–2003 | Norway | Primary osteoarthritis | 71.0 | Observational cohort, Registry | Uncemented, cemented with or without antibiotics | 12.0 | 56,275 | Revision due to infection | 252 | 8 |
| Pospula, 2008 | 1994–2004 | Kuwait | Osteoarthritis 12.6%, other 87.4% | 53.7/46.7 * | Observational cohort, Consecutive case series | All cemented, uncemented | 5.0/3.0 | 182 | Infection | 5 | 6 |
| Hooper, 2009 | 1999–2006 | New Zealand | All indications | <55 to >75 | Observational cohort, Registry | All cemented, hybrid, uncemented | < and >90 days | 42,665 | Revision due to infection | 143 | 6 |
| Dale, 2009 | 1987–2007 | Norway | Osteoarthritis 72.2%, inflammatory 3.7%, other 24.1% | <40 to ≥80 | Observational cohort, Registry | Uncemented and cemented with or without antibiotics | 5.0 | 97,344 | Revision due to infection | 614 | 8 |
| Pedersen, 2010 | 1995–2008 | Denmark | Primary osteoarthritis 78.4%, others 21.6% | NR | Observational cohort, Registry | Hybrid, uncemented, cemented with or without antibiotics | 4.6 | 80,756 | Revision due to infection | 597 | 8 |
| Hailer, 2010 | 1992–2007 | Sweden | Primary osteoarthritis 76%, others 24% | <50 to >75 | Observational cohort, Registry | All cemented, uncemented | 5.8 | 170,413 | Revision due to infection | 852 | 8 |
| Dale, 2011 | 2005–2009 | Norway | NR | NR | Observational cohort, Registry | All cemented, uncemented, hybrid | 1.0 (median, 29 days) | 31,086 | Revision due to infection | 236 | 8 |
| Dale, 2011 | 2005–2009 | Norway | NR | NR | Observational cohort, Registry | All cemented, uncemented, hybrid | 1.0 (median, 16 days) | 5540 | Infection | 167 | 8 |
| Kim, 2011 | 1991–1993 | Korea | Osteonecrosis 66%, others 34% | 43.4/46.8 * | Observational cohort, Consecutive case series | Hybrid, uncemented | 18.4 | 219 | Infection | 4 | 7 |
| Dale, 2012 | 1995–2009 | NARA | Osteoarthritis 80%, others 20% | <40 to ≥90 | Observational cohort, Registry | Hybrid, all cemented, reverse hybrid, uncemented | 5.0 | 432,168 | Revision due to infection | 2778 | 8 |
| Takenaga, 2012 | 1994–1999/1970–1976 | USA | Osteoarthritis 11% in cemented cohort, 39% in uncemented cohort | 42.0/40.1 * | Observational cohort | All cemented, uncemented | 18.0/12.0 * | 208 | Infection | 4 | 6 |
| Bolland, 2012 | 2003–2008 | UK | NR | 64.7 | Observational cohort, Registry | All cemented, hybrid, uncemented | 3.0 | 220,399 | Revision due to infection | 406 | 7 |
| Makela, 2014 | 1995–2011 | NARA | Primary osteoarthritis 90.6%, other 9.4% | 55 and older | Observational cohort, Registry | All cemented, hybrid, reverse hybrid, uncemented | 10.0 | 347,899 | Revision due to infection | 877 | 6 |
| Wyatt, 2014 | NR | New Zealand | NR | NR | Observational cohort, Registry | All cemented, hybrid, reverse hybrid, uncemented | 13.0 | 3319 | Revision due to infection | 390 | 7 |
| Schrama, 2015 | 1995–2010 | NARA | Osteoarthritis 96.6%, rheumatoid arthritis 3.4% | 68.8 | Observational cohort, Registry | Uncemented, cemented with or without antibiotics | 16.0 | 390,671 | Revision due to infection | 2315 | 8 |
| Wangen, 2017 | 2000–2013 | NARA | Osteoarthritis 81%, others 20% | 64.0/73.0 * | Observational cohort, Registry | Reverse hybrid, all cemented | 3.3/6.2 * | 496,567 | Revision due to infection | 2309 | 8 |
| Chammout, 2017 | 2009–2014 | Sweden | Displaced femoral neck fracture | 73.0 | RCT | Reverse hybrid, all cemented | 2.0 | 69 | Infection | 1 | NA |
| Trela-Larsen, 2018 | 2003–2013 | UK | Osteoarthritis | 63.7 | Observational cohort, Registry | Cemented with antibiotics, cemented without antibiotics | 4.1 | 199,205 | Revision due to infection | 595 | 8 |
| Lenguerrand, 2018 | 2003–2013 | UK | Osteoarthritis 93%, others 7% | 68.0 | Observational cohort, Registry | All cemented, uncemented | 4.6 | 623,253 | Revision due to infection | 2705 | 8 |
NARA, Nordic Arthroplasty Register Association; NA, not applicable; NK, not known; NR, not reported; PJI, prosthetic joint infection; RCT, randomised controlled trial; THR, total hip replacement; and *, exposure fixation type vs comparison fixation type.
Figure 2Fixation types and risk of prosthetic joint infection in observational and interventional studies. CI, confidence interval (bars); PJI, prosthetic joint infection; and RR, relative risk.
Figure 3Comparison of all cemented fixation with uncemented fixation and the risk of prosthetic joint infection in observational studies, grouped according to several study characteristics. CI, confidence interval (bars); PJI, prosthetic joint infection; and RR, relative risk.